Table 2.
Repeated measures analysis of variance. Expected mean FZD7 expression and NAFLD scores (as assessed by CAP value) by time and NAFLD severity. NutriAtt Trial, Castellana Grotte, 2015–2016. Number of healthy subjects (absent) = 20, number of patients affected by moderate steatosis = 38, and severe steatosis = 57.
| FZD7 | β | SE | p-Value | (95% CI) |
|---|---|---|---|---|
| NAFLD | ||||
| Absent n = 20 | 0 | |||
| Moderate n = 38 | −9.40 | 9.87 | 0.34 | (−28.98; 10.18) |
| Severe n = 57 | 3.27 | 6.58 | 0.62 | (−9.78; 16.33) |
| Time | ||||
| Baseline | 0 | |||
| 90 days | −0.82 | 1.09 | 0.46 | (−2.99; 1.36) |
| NAFLD × Time | ||||
| Moderate × 90 days | −3.99 | 1.48 | 0.008 | (−6.94; −1.05) |
| Severe × 90 days | −11.03 | 1.26 | 0.000 | (−13.52; −8.53) |